Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant, J&J in Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Jubilant, J&J in Discovery Pact

Three-year deal will focus on neuroscience candidates

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Jubilant Discovery Services, a Jubilant Life Sciences Company, has entered into a drug discovery alliance with Janssen Pharmaceutica N.V., Beerse, Belgium. The alliance is set to span an initial period of three years and will focus on multiple targets in the area of neuroscience.

Janssen will transfer ongoing efforts on selected drug discovery targets to Jubilant. Jubilant will carry out research services and deliver preclinical candidates to Janssen for possible further development and commercialization. In addition to research funding, Jubilant may also be eligible to receive milestones and royalties should Janssen successfully develop and commercialize the candidates.

Commenting on this development, Sri Mosur, Jubilant’s chief executive officer and president, Global Drug Discovery & Development, remarked, “The collaboration will utilize Jubilant’s global research network to include our new research facility in the U.S. focused in the area of neuroscience, in addition to our India-based research centers. We look forward to enhancing the research and development efforts at Janssen through this unique and creative alliance in these dynamic times in the industry.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics